BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lesueur P, Lequesne J, Barraux V, Kao W, Geffrelot J, Grellard JM, Habrand JL, Emery E, Marie B, Thariat J, Stefan D. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer). Radiat Oncol 2018;13:138. [PMID: 30055640 DOI: 10.1186/s13014-018-1083-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Wei Z, Waite K, Deng H, Najjar Y, Niranjan A, Lunsford LD. Aggressive Stereotactic Radiosurgery Coupled With Immune and Targeted Therapy for Recurrent Melanoma Brain Metastases: A Case Report and Literature Review. Cureus 2022. [DOI: 10.7759/cureus.26553] [Reference Citation Analysis]
2 Pierrard J, Tison T, Grisay G, Seront E. Global management of brain metastasis from renal cell carcinoma. Critical Reviews in Oncology/Hematology 2022. [DOI: 10.1016/j.critrevonc.2022.103600] [Reference Citation Analysis]
3 Loo M, Clavier JB, Attal Khalifa J, Moyal E, Khalifa J. Dose-Response Effect and Dose-Toxicity in Stereotactic Radiotherapy for Brain Metastases: A Review. Cancers (Basel) 2021;13:6086. [PMID: 34885193 DOI: 10.3390/cancers13236086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Kaul D, Berghoff AS, Grosu AL, Lucas CW, Guckenberger M. Focal Radiotherapy of Brain Metastases in Combination With Immunotherapy and Targeted Drug Therapy. Dtsch Arztebl Int 2021:arztebl. [PMID: 34730083 DOI: 10.3238/arztebl.m2021.0332] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Uto M, Ogura K, Katagiri T, Takehana K, Mizowaki T. Interfractional target changes in brain metastases during 13-fraction stereotactic radiotherapy. Radiat Oncol 2021;16:140. [PMID: 34321033 DOI: 10.1186/s13014-021-01869-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Petoukhova A, Snijder R, Wiggenraad R, de Boer-de Wit L, Mudde-van der Wouden I, Florijn M, Zindler J. Quality of Automated Stereotactic Radiosurgery Plans in Patients with 4 to 10 Brain Metastases. Cancers (Basel) 2021;13:3458. [PMID: 34298671 DOI: 10.3390/cancers13143458] [Reference Citation Analysis]
7 Ruste V, Sunyach MP, Tanguy R, Jouanneau E, Schiffler C, Carbonnaux M, Moriceau G, Neidhardt EM, Boyle H, Robin S, Négrier S, Fléchon A. Synchronous brain metastases as a poor prognosis factor in clear cell renal carcinoma: a strong argument for systematic brain screening. J Neurooncol 2021;153:133-41. [PMID: 33837880 DOI: 10.1007/s11060-021-03751-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Samanci Y, Karakose F, Senyurek S, Peker S. Single-fraction versus hypofractionated gamma knife radiosurgery for small metastatic brain tumors. Clin Exp Metastasis 2021;38:305-20. [PMID: 33733707 DOI: 10.1007/s10585-021-10086-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Telentschak S, Ruess D, Grau S, Goldbrunner R, von Spreckelsen N, Jablonska K, Treuer H, Kocher M, Ruge M. Cyberknife® hypofractionated stereotactic radiosurgery (CK-hSRS) as salvage treatment for brain metastases. J Cancer Res Clin Oncol 2021;147:2765-73. [PMID: 33638006 DOI: 10.1007/s00432-021-03564-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Chen JJ, Sullivan AJ, Shi DD, Krishnan MS, Hertan LM, Roldan CS, Huynh MA, Spektor A, Fareed MM, Lam TC, Balboni TA. Characteristics and Predictors of Radiographic Local Failure in Patients With Spinal Metastases Treated With Palliative Conventional Radiation Therapy. Adv Radiat Oncol 2021;6:100665. [PMID: 33817411 DOI: 10.1016/j.adro.2021.100665] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Stenman M, Benmakhlouf H, Wersäll P, Johnstone P, Hatiboglu MA, Mayer-da-Silva J, Harmenberg U, Lindskog M, Sinclair G. Metastatic renal cell carcinoma to the brain: optimizing patient selection for gamma knife radiosurgery. Acta Neurochir (Wien) 2021;163:333-42. [PMID: 32902689 DOI: 10.1007/s00701-020-04537-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Scharl S, Kessel KA, Diehl C, Gempt J, Meyer B, Zimmer C, Straube C, Combs SE. Is local radiotherapy a viable option for patients with an opening of the ventricles during surgical resection of brain metastases? Radiat Oncol 2020;15:276. [PMID: 33303000 DOI: 10.1186/s13014-020-01725-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Scaria B, Sood S, Raad C, Khanafer J, Jayachandiran R, Pupulin A, Grewal S, Okoko M, Arora M, Miles L, Pandey S. Natural Health Products (NHP's) and Natural Compounds as Therapeutic Agents for the Treatment of Cancer; Mechanisms of Anti-Cancer Activity of Natural Compounds and Overall Trends. Int J Mol Sci 2020;21:E8480. [PMID: 33187200 DOI: 10.3390/ijms21228480] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
14 Dohopolski M, Hannan R, Wardak Z, Hammers H, Garant A. The Reintroduction of Radiotherapy Into the Integrated Management of Kidney Cancer. Cancer J 2020;26:448-59. [PMID: 32947313 DOI: 10.1097/PPO.0000000000000475] [Reference Citation Analysis]
15 Napolitano M, Ranieri A, Maniscalco GT, Riccardi F, De Dominicis G, Caiazzo P. Brain Radionecrosis After Adjuvant Radiation Therapy for a Primary Intracerebral Undifferentiated Sarcoma. World Neurosurg 2020;143:285-8. [PMID: 32763370 DOI: 10.1016/j.wneu.2020.07.174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 de la Pinta C, Fernández-Lizarbe E, Sevillano D, Capúz AB, Martín M, Hernanz R, Vallejo C, Martín M, Sancho S. Brain metastases: Single-dose radiosurgery versus hypofractionated stereotactic radiotherapy: A retrospective study. J Clin Transl Res 2020;6:6-13. [PMID: 32875136] [Reference Citation Analysis]
17 Ramos RI, Bustos MA, Wu J, Jones P, Chang SC, Kiyohara E, Tran K, Zhang X, Stern SL, Izraely S, Sagi-Assif O, Witz IP, Davies MA, Mills GB, Kelly DF, Irie RF, Hoon DSB. Upregulation of cell surface GD3 ganglioside phenotype is associated with human melanoma brain metastasis. Mol Oncol 2020;14:1760-78. [PMID: 32358995 DOI: 10.1002/1878-0261.12702] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
18 Mengue L, Bertaut A, Ngo Mbus L, Doré M, Ayadi M, Clément-Colmou K, Claude L, Carrie C, Laude C, Tanguy R, Blanc J, Sunyach MP. Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation. Radiat Oncol 2020;15:82. [PMID: 32303236 DOI: 10.1186/s13014-020-01517-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
19 Sinclair G, Stenman M, Benmakhlouf H, Johnstone P, Wersäll P, Lindskog M, Hatiboglu MA, Harmenberg U. Adaptive radiosurgery based on two simultaneous dose prescriptions in the management of large renal cell carcinoma brain metastases in critical areas: Towards customization. Surg Neurol Int 2020;11:21. [PMID: 32123609 DOI: 10.25259/SNI_275_2019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Bracarda S, Mosillo C, Trippa F, Urbano F, Maranzano E, Caserta C. No paradigm changes with checkpoint inhibitor monotherapy in patients with metastatic renal cell carcinoma and brain metastases. Ann Transl Med 2019;7:612. [PMID: 31930013 DOI: 10.21037/atm.2019.11.50] [Reference Citation Analysis]
21 Su Z, Zhou L, Xue J, Lu Y. Integration of stereotactic radiosurgery or whole brain radiation therapy with immunotherapy for treatment of brain metastases. Chin J Cancer Res 2020;32:448-66. [PMID: 32963458 DOI: 10.21147/j.issn.1000-9604.2020.04.03] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
22 Marques C, Chang EL. Stereotactic Radiosurgery for Brain Metastases. Central Nervous System Metastases 2020. [DOI: 10.1007/978-3-030-23417-1_17] [Reference Citation Analysis]
23 Sayan M, Zoto Mustafayev T, Sahin B, Kefelioglu ESS, Wang SJ, Kurup V, Balmuk A, Gungor G, Ohri N, Weiner J, Ozyar E, Atalar B. Evaluation of response to stereotactic radiosurgery in patients with radioresistant brain metastases. Radiat Oncol J 2019;37:265-70. [PMID: 31918464 DOI: 10.3857/roj.2019.00409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
24 Donovan EK, Parpia S, Greenspoon JN. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis. Curr Oncol 2019;26:e328-33. [PMID: 31285676 DOI: 10.3747/co.26.4749] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
25 Rogers SJ, Puric E, Eberle B, Datta NR, Bodis SB. Radiotherapy for Melanoma: More than DNA Damage. Dermatol Res Pract 2019;2019:9435389. [PMID: 31073304 DOI: 10.1155/2019/9435389] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
26 Yang I, Udawatta M, Prashant GN, Lagman C, Bloch O, Jensen R, Sheehan J, Kalkanis S, Warnick R. Stereotactic Radiosurgery for Neurosurgical Patients: A Historical Review and Current Perspectives. World Neurosurg 2019;122:522-31. [PMID: 30399473 DOI: 10.1016/j.wneu.2018.10.193] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]